Literature DB >> 34150045

Effect of comprehensive nursing on the pain, anxiety and malnutrition of hepatitis B patients.

Feifei Chen1, Xiaoqun Pang2, Xiaoling Dai3.   

Abstract

OBJECTIVE: To explore the effect of comprehensive nursing on pain, anxiety and malnutrition of hepatitis B patients.
METHODS: Totally 100 cases of hepatitis B patients received treatment in our hospital from July 2017 to July 2018 were divided into a study group (64 cases) and a control group (36 cases) for comprehensive nursing and routine nursing. The liver function, nutritional indexes, cognition of relevant nursing knowledge, VAS score, HAMD and HAMA scores, QOL score, total effective rate and incidence of adverse reactions were detected.
RESULTS: Compared with the control group, the study group had lower liver function indexes and higher nutrition indexes, suggesting that the liver function of patients in the study group recovered better. Besides, the VAS score of the study group was lower, suggesting better pain relief in the study group. Moreover, the study group had higher scores of related nursing knowledge and lower scores of HAMD and HAMA, indicating that the nursing method in the study group was more effective in reducing depression and anxiety. Higher QOL score, higher total effective rate and lower incidence of adverse reactions of the study group revealed that the nursing mode adopted in this group was better for the recovery of patients.
CONCLUSION: Comprehensive nursing can effectively alleviate the pain of hepatitis B patients, relieve their anxiety and other negative emotions, and improve their malnutrition. AJTR
Copyright © 2021.

Entities:  

Keywords:  ALT; AST; Comprehensive nursing; TBIL; hepatitis B

Year:  2021        PMID: 34150045      PMCID: PMC8205827     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  23 in total

Review 1.  Management of treatment failure in chronic hepatitis B.

Authors:  Fabien Zoulim; Stephen Locarnini
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

2.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY.

Authors:  Yehuda Handelsman; Zachary T Bloomgarden; George Grunberger; Guillermo Umpierrez; Robert S Zimmerman; Timothy S Bailey; Lawrence Blonde; George A Bray; A Jay Cohen; Samuel Dagogo-Jack; Jaime A Davidson; Daniel Einhorn; Om P Ganda; Alan J Garber; W Timothy Garvey; Robert R Henry; Irl B Hirsch; Edward S Horton; Daniel L Hurley; Paul S Jellinger; Lois Jovanovič; Harold E Lebovitz; Derek LeRoith; Philip Levy; Janet B McGill; Jeffrey I Mechanick; Jorge H Mestman; Etie S Moghissi; Eric A Orzeck; Rachel Pessah-Pollack; Paul D Rosenblit; Aaron I Vinik; Kathleen Wyne; Farhad Zangeneh
Journal:  Endocr Pract       Date:  2015-04       Impact factor: 3.443

Review 3.  Current developments in nucleoside/nucleotide analogues for hepatitis B.

Authors:  Angeline Oi-Shan Lo; Grace Lai-Hung Wong
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-04-30       Impact factor: 3.869

Review 4.  Virus and Host Testing to Manage Chronic Hepatitis B.

Authors:  Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Henry Lik-Yuen Chan
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

5.  Standards of medical care in diabetes-2015 abridged for primary care providers.

Authors: 
Journal:  Clin Diabetes       Date:  2015-04

Review 6.  Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives.

Authors:  Tung-Hung Su; Chun-Jen Liu
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

7.  Age-dependent changes in cardiac performance, motor function, QoL, and mental status in metoprolol-treated chronic heart failure patients.

Authors:  Qiuhong Shu; Liyong Wu; Ran Zhang; Qian Zhang; Jingjing Huang; Yong Meng
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

8.  Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate.

Authors:  In Suk Min; Chang Hun Lee; Ik Sang Shin; Na Eun Lee; Hong Seon Son; Seung Bum Kim; Seung Young Seo; Seong Hun Kim; Sang Wook Kim; Seung Ok Lee; Soo Teik Lee; In Hee Kim
Journal:  Gut Liver       Date:  2019-01-15       Impact factor: 4.519

9.  Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.

Authors:  Linlin Yan; Yongqiong Deng; Jiyuan Zhou; Hong Zhao; Guiqiang Wang
Journal:  Infection       Date:  2018-03-29       Impact factor: 3.553

10.  Chart review of patients receiving valsartan-amlodipine single-pill combination versus valsartan and amlodipine combination for blood pressure goal achievement and effects on the Hamilton anxiety rating/Hamilton depression rating scales.

Authors:  Gang Yin; Yuefan Li; Wenjie Xu; Na Han
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.